Feature | Cardiovascular Business | December 18, 2007 | Dave Fornell

Don’t Overlook the Simple Questions When Purchasing New Technology


Common sense is probably the biggest factor to use as a guide when looking to buy new medical technology and equipment. However, sometimes emotions, territorial department heads, old-school resistance to change and personal preferences influence or override the decision-making process in any profession. To overcome these issues, the basis for any medical evaluation committee should make it a priority to answer one central question: What is best for the patient?

When I attended the 2007 American Society of Anesthesiologists annual meeting in San Francisco in October, I listened in on a refresher course for evaluating new technology, presented by John Abenstein, M.D., Department of Anesthesiology at the Mayo Clinic, Rochester, Minn.

He said committees need to establish criteria for evaluating new technology. The key questions include: Does the technology work, what studies confirm its effectiveness, can the technology work in a real-life situation as opposed to a clinical research facility and will it make clinically relevant differences in outcomes?

A committee should consider if the old equipment still has technical support and if spare parts are available. Will the new equipment do more and will it save time and money? What problem is the new technology going to solve? Dr. Abenstein suggests visiting the factory to see how the devices are made. Is the factory clean and organized? If not, he questions the quality of the machines.

He says to figure in the stability of a company. If a company is not in business three years after you purchase equipment, it will not help your long-term use of the equipment.

All sorts of justifications will be used to sway people to believe new technology is needed. Dr.Abenstein said people should not buy into emotional appeals that the technology is needed for children's or women’s health or else the hospital will not be supporting those causes. He says the bottom line is to ask if the new technology works and if it will significantly improve outcomes and be cost effective.

Some will argue equipment is needed to meet a regulatory mandate. If that argument is used, committees should ask to see the mandate in writing. Dr. Abenstein said many times it is not a mandate, but rather a suggested guideline.

Committees should also look at patient safety issues and consider standardization as a goal. If a hospital uses numerous types of machines for the same function it can lead to errors due to confusion between the different operabilities, or people not knowing how to use a machine they are not used to.
 

Related Content on the Basics of Evaluating New Technology

The Basics for Evaluating New Technology

Four Key Themes Emerging in the Medical Technology Market

Drawing the Line When Evaluating Cost vs. Benefit


Related Content

News | Cardiovascular Business

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
News | Cardiovascular Business

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

Home April 05, 2024
Home
News | Cardiovascular Business

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

Home April 05, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health ...

Home April 04, 2024
Home
News | Cardiovascular Business

March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 19, 2024 — Titan Medical Inc. announced that it has entered into a definitive amalgamation agreement (the ...

Home March 19, 2024
Home
News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 15, 2024 —Renowned cardiovascular surgeon Gilbert H. L. Tang, MD, has been named Editor-in-Chief of JACC: Case ...

Home March 15, 2024
Home
News | Cardiovascular Business

March 13, 2024 — Two nationally recognized cardiovascular programs, New Jersey-based Atlantic Health System’s Morristown ...

Home March 13, 2024
Home
News | Cardiovascular Business

March 11, 2024 — VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart ...

Home March 11, 2024
Home
Subscribe Now